MedPath

Hydroxyethyl Starch

Generic Name
Hydroxyethyl Starch
Brand Names
Hespan, Hextend, Volulyte, Voluven
Drug Type
Small Molecule
CAS Number
9005-27-0
Unique Ingredient Identifier
875Y4127EA
Background

Hydroxyethyl starch (HES/HAES) is a nonionic starch derivative. Hydroxyethyl starches (HES) are synthetic colloids commonly used for fluid resuscitation to replace intravascular volume.

HES is a general term and can be sub-classified according to average molecular weight, molar substitution, concentration, C2/C6 ratio and Maximum Daily Dose.

Indication

An intravenous solution of hydroxyethyl starch is used to prevent shock following severe blood loss caused by trauma, surgery, or other issues.

Associated Conditions
Hypovolaemia
Associated Therapies
Granulocyte yield increase

Hydroxyethyl Starch (130/0.4) for Intravascular Volume Therapy in Liver Transplantation

Phase 4
Terminated
Conditions
Intraoperative Complications
Interventions
First Posted Date
2006-03-29
Last Posted Date
2009-01-15
Lead Sponsor
Fresenius Kabi
Target Recruit Count
53
Registration Number
NCT00308100
Locations
🇨🇳

People's Hospital of Peking University, Beijing, China

Hetastarch and Bleeding Complications After Off-Pump Coronary Bypass Surgery

Phase 3
Completed
Conditions
Postoperative Hemorrhage
First Posted Date
2006-03-27
Last Posted Date
2006-05-22
Lead Sponsor
Kaiser Permanente
Target Recruit Count
330
Registration Number
NCT00307138
Locations
🇺🇸

Summit Medical Center, Oakland, California, United States

Safety/Feasibility Study of HBOC-201 in Amputation at/Below Knee From Critical Lower Limb Ischemia

Phase 2
Terminated
Conditions
Peripheral Vascular Disease
Interventions
First Posted Date
2006-03-08
Last Posted Date
2008-05-16
Lead Sponsor
Biopure Corporation
Target Recruit Count
16
Registration Number
NCT00300040
Locations
🇿🇦

University of Stellenbosch, Tygerburg, South Africa

🇿🇦

Milpark Hospital, Parktown West, Guateng, South Africa

🇬🇧

John Radcliffe Hospital, Headington, Oxfordshire, United Kingdom

and more 2 locations

Influence of Hydroxyehtyl Starch (HES) on Hemorehology, Coagulation and Elimination Kinetics

Not Applicable
Completed
Conditions
Stroke Patients Presenting Within 24 Hrs of Onset of Symptoms
First Posted Date
2005-11-21
Last Posted Date
2006-04-19
Lead Sponsor
Nizam's Institute of Medical Sciences University, India
Target Recruit Count
20
Registration Number
NCT00255957
© Copyright 2025. All Rights Reserved by MedPath